Incyte's Reverset Finds Place Among Soldiers In AIDS Battle
Though mostly off the front pages these days, the war against HIV goes on - and last week a new therapeutic recruit showed some of its colors, as Incyte Corp. unveiled data from a Phase IIb trial with the once-daily pill Reverset, yet another nucleoside analogue reverse transcriptase inhibitor (NRTI).
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter